Virtual Currency – Maintaining Compliance with Regulations

In the recent years, virtual currencies have gained a lot of prominence in the real world. Different types of virtual currencies have evolved, which have also resulted in the increased risks in the areas of information technology, compliance, and financial crime. Virtual currencies are available in the digital form and do not follow the same regulations as the e-money (traditional currency exchanged electronically).  However, with the growing popularity of virtual currencies, regulatory expectations and guidance on their risk management are also emerging at a fast pace. Failure to meet the regulations may lead to severe consequences like criminal or civil penalties, in case the money is laundered through the virtual currency system. Continue reading “Virtual Currency – Maintaining Compliance with Regulations”

Anti Money Laundering in the Digital Era

Money laundering continues to be a major issue in the financial ecosystem but the methods are changing drastically in this technology-driven era. The Bank Secrecy Act (BSA) was introduced long back, mandating the reporting of suspected fraud or laundering. However, now the Financial Crimes Enforcement Network (FinCEN) has modified and expanded the anti-money laundering (AML) requirements. Financial organizations now have rules, outlined by the Department of the Treasury agency, to include reporting cyber-enabled crime and cyber-events through Suspicious Activity Reports (SARs). Apart from including the questionable activity by customers, the updated rules also include suspicious activity on the bank level.  Continue reading “Anti Money Laundering in the Digital Era”

Evolution Of Digitalized Pharmaceutical Industry

With the evolution of pharmaceutical industry, the advent of digital tools, processes and platforms has also been prominent. This has dramatically transformed the facet of clinical trials and is making way for new opportunities to improve the trial processes further. However, in this changing scenario, the professionals need to develop new systems and procedures to evaluate new technologies and analyze if these can streamline the trail experiences. Continue reading “Evolution Of Digitalized Pharmaceutical Industry”

Rules And Regulations Surrounding HIPAA Data Breach

With the implementation of new technologies, adoption of electronic health record technology and association with health information exchanges, more healthcare organizations are exposing themselves to HIPAA data breaches and other online threats. In this scenario Protected Health Information (PHI), in addition to being available to the concerned people, is also becoming more and more accessible to hackers and unauthorized third parties. This means covered entities and business associates need to stay updated about the advancing technologies to maintain PHI security. Understanding the basics and underlying reasons for HIPAA data breach is the first step in creating comprehensive data security plans which the healthcare organizations can apply to their daily operations.  Continue reading “Rules And Regulations Surrounding HIPAA Data Breach”

Double Up Your Learning Benefits With HRCI And SHRM Approved Webinars

A Continuing Education Credit (CEC) or Continuing Education Unit (CEU) refers to a measure used in continuing education programs for helping professionals maintain their license in the profession. Continuing education is mandatory in several fields and is described as participation in different educational programs and activities. Continue reading “Double Up Your Learning Benefits With HRCI And SHRM Approved Webinars”

Technology Based Protocol Development in Pharmaceutical Industry

With the evolution of the pharmaceutical industry, the advent of digital tools, processes, and platforms has also been prominent. This has dramatically transformed the face of clinical trials and is making way for new opportunities to improve the trial processes further. However, in this changing scenario, the professionals need to develop new systems and procedures to evaluate new technologies and analyze if these can streamline the trail experiences. Continue reading “Technology Based Protocol Development in Pharmaceutical Industry”